BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair DeviceLAVAL, Canada - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced statistically significant results from an analysis of patients who completed their 12 month follow-up in the BST-CarGel(R) randomized clinical trial. Specifically, statistically significant evidence of improved repair tissue quality due to BST-CarGel treatment was found during analyses of tissues biopsied from the knees of 22 patients. The ongoing multicentre pivotal trial is evaluating the ability of BST-CarGel to repair cartilage lesions in the knee when applied to a microfractured lesion compared to microfracture alone (control) in 80 patients. Final results on all 80 patients are expected in the first half of 2010. Microlife WatchBP Invites Medical Professionals for a ‘New way through together’ at ESH MeetingWIDNAU, Switzerland - By Guideline-Based Solution for Blood Pressure Measurement — Microlife WatchBP(R) Chiesi Creates New Research Centre to Study Innovative Therapies for the Treatment of Respiratory and Special Care DiseasesPARMA, Italy - The centre, which is to be located in Parma over an area of 22,000 sq. m., will be operative from 2011 and will employ over 300 qualified researchers from both Italy and abroad. The investment is worth around euro 70 million. The aim of the centre is the study of innovative products for chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and special care diseases such as cystic fibrosis and respiratory distress syndrome in premature infants. Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly PatientsSEATTLE - Neurim Pharmaceuticals (www.neurim.com) presented today the preliminary results of a large-scale Phase III study of Circadin(R) 2mg, prolonged release melatonin in insomnia, demonstrating long term efficacy and safety in elderly patients. The results were reported in the Late Breaking Abstracts session of SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, (APSS) held at Seattle, Washington. The SLEEP meeting attracts the largest audience of sleep specialists in world. Frost & Sullivan: Replacement of Old Equipment Boosts Kenyan Medical Imaging IndustryCAPE TOWN, South Africa - The medical imaging market in Kenya is set for steady growth over the next five years, driven by an aging population demanding greater access to imaging and diagnostic procedures. However, price sensitivity and competition in the market remain high due to the sizeable capital investment required to purchase imaging systems and the financial constraints faced by many healthcare institutions in the country. Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009MINNEAPOLIS - Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, introduced its Model 7600 Regional Oximetry System at the European Society of Anaesthesiology (ESA) conference in Milan, Italy. Designed for instantaneous signal acquisition, improved accuracy and consistency during cerebral monitoring, the Model 7600 offers real-time management of cerebral oxygenation for patients at risk of ischemia. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy MarketVEENENDAAL, The Netherlands - Nucletron BV, the innovative cancer radiation solutions company, today announced the creation of an exclusive partnership and plan to merge with sector peer Isodose Control BV for an undisclosed sum. The two companies, headquartered in Veenendaal and Ede, the Netherlands, are complementary and the combination will strengthen Nucletron’s position as global leader in the market for high-precision radiation therapy equipment and software, or brachytherapy. Ingenuity and Integromics Offer Integration for Comprehensive Genomics AnalysisREDWOOD CITY, California - Integromics, S.L. and Ingenuity Systems announced the integration of RealTime StatMiner(R) and Integromics Biomarker Discovery(TM) (IBD) for TIBCO Spotfire(R) with Ingenuity Pathway Analysis (IPA). The resulting platform provides a uniform solution for researchers to visualize and statistically assess genomics data, and then identify relevant biological processes and pathways. Researchers can now leverage a streamlined workflow to send the data from RealTime StatMiner(R), a step-by-step workflow-oriented solution for RT-qPCR data analysis, and IBD for TIBCO Spotfire(R) , an application to pre-process, normalize, and interpret raw microarray gene expression data, directly into IPA for better modeling, analysis, and understanding of their biological data. Clinical Trial Results of Pollogen’s TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and VenereologyTEL AVIV, Israel - TriPollar(TM) Technology Proven as an Effective Modality for Immediate and Long Term Body Contouring and Circumference Reduction Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck CancerMADRID - Phase 3 study has demonstrated that Induction Chemotherapy prior to ChemoRadiotherapy significantly increased time-to-treatment failure in comparison to standard ChemoRadiotherapy alone - Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in ChinaDUSSELDORF, Germany - Now Seven Plants in China The Gerresheimer Group today opened a new plant for pharmaceutical glass packaging in China. The high-tech production facility constructed in Danyang (Jiangsu Province) covers 16,000 square meters. Specializing in high-quality pharmaceutical vials and cartridges for injection systems it serves the pharma & life science industry on both a local and international level. Dr. Axel Herberg, CEO of Gerresheimer AG, describes the investment as a very important strategic step for further business expansion in Asia. In China, Gerresheimer now operates seven production plants for highly specific glass and plastic products. The Hidden Heart ProblemLONDON - YouGov Survey Reveals Low Awareness of Potentially Fatal Heart Condition That Affects Significant Number of People in UK Aircraft Medical Enters Anaesthesia Monitoring Market With Acquisition of Morpheus Medical, S.L.EDINBURGH, Scotland - Aircraft Medical (Aircraft), the UK medical devices company, today announces that it has entered the emergent Depth of Anaesthesia monitoring market with the acquisition of Morpheus Medical (Morpheus), the Barcelona-based developer of medical equipment. Agendia Opens CLIA-Registered U.S. Genomics LaboratoryHUNTINGTON BEACH, California and AMSTERDAM - Agendia Increases U.S. Footprint with Domestic Executive Team and Operations Bethesda-Based NHSi Wins US$2M Grant for Blood TechnologyBETHESDA, Maryland - New Health Sciences Inc. (NHSi) has won a two-year award of US$1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a groundbreaking blood-storage system. New Findings Provide Additional Insights into the Management of Anaemia and Secondary Hyperparathyroidism in Chronic Kidney Disease PatientsMILAN - Data presented from large-scale observational studies provide new insights into the day-to-day management of two major complications of CKD: anaemia and secondary hyperparathyroidism (SHPT).(1), (2), (3), (4) AMG International Announces the European Regulatory Submission of its Next Generation of Coronary Drug Stents ‘Itrix’ at European PCR Congress in Barcelona, SpainBARCELONA, Spain - German Medical Device Manufacturer AMG International GmbH announced the submission of its proprietary Itrix Stent Technology using its patented biodegradable drug coating. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist SystemANN ARBOR, Michigan - Terumo Heart Inc., a wholly owned subsidiary of Terumo Corporation, today announced reaching a critical milestone in the worldwide expansion of its DuraHeart(TM) Left-Ventricular Assist System (LVAS) as the 100th patient was treated by Latif Arusoglu, MD and Michiel Morshuis, MD, cardiothoracic surgeons at the Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University of Bochum in Bad Oeynhausen, Germany. First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging CatheterBURLINGTON, Massachusetts and ROTTERDAM, Netherlands - InfraReDx, Inc. announced today the first use in patients of a novel coronary catheter that uses both light and sound to image coronary plaques. Working on a team led by Dr. Patrick Serruys, Dr. Martin van der Ent performed the procedures on May 11, 2009 in patients undergoing coronary angiography at the Thoraxcenter. Copan and POCARED Diagnostics Partner to Enhance the Use of Liquid Based Microbiology and Introduce the Next Generation Microbiology SystemsBRESCIA, Italy - Alliance Aims to Develop Powerful Tools for Accurate and Rapid Microbiology Testing Leading to Improved Patient Outcomes CeloNova BioSciences Announces Symposium about CATANIA(TM) Coronary Stent at EuroPCRBARCELONA, Spain - CeloNova BioSciences, Inc., today announced that it will showcase the technology behind the CATANIA(TM) Coronary Stent System featuring a NanoThin Polyzene(R)-F surface treatment as part of the Company’s participation in the EuroPCR conference May 19-22. First 100 Patients Treated in Europe with the MitraClip(R) System for Percutaneous Mitral RepairMENLO PARK, California - Use of the MitraClip(R) Therapy Continues to Expand in Europe Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip(R) system in Europe. Clinical results to date underscore the acute clinical benefit for patients, demonstrate the potential for reduced hospital stays and improved quality-of-life for patients. Of the procedures performed to date, 93% resulted in an implant and the vast majority resulted in a satisfactory reduction of mitral regurgitation, as described by the physician at the time of the procedure. The MitraClip(R) system is the only medical device commercially available in the European Union which provides a non-surgical mitral valve repair option for patients suffering from the effects of functional or degenerative mitral regurgitation (MR). Occlutech Obtains CE Mark for the new Generation PFO & ASD OccludersJENA, Germany - Occlutech, the leading European developer of septum occluders, today announced that it has obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex. Standard & Poor’s Confirms Rating for GerresheimerDUSSELDORF, Germany - The rating agency Standard & Poor’s has today confirmed the current rating of BB+ for the Gerresheimer Group and continues to categorize the outlook as stable. The focus of the MDAX company on the pharma & life science industry is therefore assessed as positive and sustainable by the rating agency. Dr. Tanaka Appointed as Honorary Consul-General by Republic of SingaporeNAGOYA, Japan - Dr. Hidenari Tanaka, president and CEO of Menicon Co., Ltd. and president of the Japan Contact Lens Association, was appointed as Singapore’s Honorary Consul-General in Nagoya, Japan, by the government of the Republic of Singapore. The appointment was effective April 20, 2009. The Singapore Consulate-General will be located at Menicon’s corporate headquarters in Nagoya. Archimedes Pharma Announces Ground-Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer PainREADING, England - Meets Primary Efficacy Endpoint - First Study of a Next-Generation Fentanyl-Based Product to Show Superiority Over Immediate Release Morphine Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast CancerMARSEILLE, France - The Genomic HR Test Will Help Pathologists to Identify Endocrine-Responsive Tumors That Should Benefit From Hormonotherapy Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & SullivanCAPE TOWN, South Africa - Increased public and private expenditure on healthcare, coupled with increasing levels of medical insurance coverage and continued foreign donor funding are creating significant opportunities for growth within the Kenyan healthcare industry. The pharmaceutical and medical devices industries will exhibit continued expansion as the government boosts the allocation of resources for regulatory enforcement. Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1PLAN-LES-OUATES, Switzerland - Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e. 100 times better and a peak performance of 1000 times, against avian influenza virus H5N1. Disposable facemasks are thus far not very effective against viruses, such as influenza, whose sizes are 0.02 to 0.3 microns. Swine Flu: Filtering Fact From Fiction About Face MasksSOUTHAMPTON, England - “Face Masks Need Filters to Provide Optimal Protection From Swine Flu” Nfocus Neuromedical Elects Eric P. Milledge Chairman of BoardPALO ALTO, California - Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer. Nfocus Neuromedical Appoints Robert O’Holla to Head RegulatoryPALO ALTO, California - Accomplished regulatory executive enhances Nfocus device development team. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical LiaisonCOMMACK, New York - It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief Clinical Liaison. Working Towards ‘Counting Malaria Out’ Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide ResistanceLAUSANNE, Switzerland - World Malaria Day Events Held in Nairobi, London, Washington To honor the theme for World Malaria Day on 4/25, ‘Counting Malaria Out,’ Vestergaard Frandsen is stepping up production of its best selling bed net, called PermaNet(R), and introducing a new version that is effective against insecticide resistant mosquitoes. Comic Relief Invests GBP6.3m to Tackle MalariaLONDON - Just days ahead of World Malaria Day 2009 Comic Relief has awarded GBP6.3m in funding to Malaria Consortium and the Global Fund to help protect over 1m people in Africa from malaria. |
